Plasma lipoproteins in soy-treated postmenopausal women: A double-blind, placebo-controlled trial

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 10, Issue 6, 2000, Pages 315-322

  Vigna, G B ^a   Pansini, F ^a   Bonaccorsi, G ^a   Albertazzi, P ^a   Donega P ^a   Zanotti, L ^a   De Aloysio, D ^b   Mollica, G ^a   Fellin, R ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Apolipoproteins; Lipoprotein(a); Lipoproteins; Menopause; Phytoestrogens; Soy

Indexed keywords

CASEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; HEART MUSCLE ISCHEMIA; HOT FLUSH; HUMAN; MIDDLE AGED; MULTICENTER STUDY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

CASEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DOUBLE-BLIND METHOD; FEMALE; HOT FLASHES; HUMANS; LIPIDS; LIPOPROTEINS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POSTMENOPAUSE; SOYBEAN PROTEINS; TRIGLYCERIDES;

EID: 0034569748     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Hallen S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, for the Hearth and Estrogen/progestin Replacement Study (HERS) Research Group (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women, JAMA 280: 605-613
2. Rossouw JE (1999) Hormone replacement therapy and cardiovascular disease. Curr Opin Lipidol 10: 429-434
3. Newnham HH (1993) Oestrogens and atherosclerotic vascular disease. Lipid factors. Baillière's Clin Endocrinol Metab 7: 61-93
4. Pansini F, Bergamini C, Bettocchi S, Bassi P, Malfaccini M, Bagni B, Mollica G (1984) Short-term effect of oophorectomy on lipoprotein metabolism. Gynecol Obstet Invest 18: 134-139
5. Soma MR, Osnago-Gadda 1, Paoletti R, Fumagalli R, Morrisett JD, Meschia M, Crosignani P (1993) The lowering of lipoprotein(a) induced by estrogen plus progestogen replacement therapy in postmenopausal women. Arch Intern Med 153: 1462-1468
6. The Writing Group for the PEPI trial (1995) Effects of estrogen or estrogen progestin regimens on heart disease risk factors in postmenopausal women: the postmenopausal estrogen/progestins (PEPI) trial. JAMA 273: 199-208
7. Marcovina SM, Koschinsky ML (1998) Lipoprotein(a) as a risk factor for coronary artery disease. Am J Cardiol 82: 57U-66U
8. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE (1995) The use of estrogen and progestin and the risk of breast cancer in postmenopausal women. N Engl J Med 332: 1589-1593
9. Gutthann SP, Rodríguez LAG, Castellsague J, Oliart AD (1997) Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. BMJ 314: 796-800
10. Knight DC, Eden JA (1996) A review of the clinical effects of phytoestrogens. Obstet Gynecol 87: 897-904
11. Murkies AL, Lombard C, Strauss BJ, Wilcox G, Burger HG, Morton MS (1995) Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas 21: 189-195
12. Carroll KK, Kurowska EM (1995) Soy consumption and cholesterol reduction: review of animal and human studies. J Nutr 125: 594S-597S
13. Lovati MR, Manzoni C, Corsini A, Granata A, Frattini R, Fumagalli R, Sirtori C (1992) Low density lipoprotein receptor activity is modulated by soybean globulins in cell culture. J Nutr 122: 1971-1978
14. Potter SM (1995) Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 125: 606S-611S.
15. Wroblewski Lissin L, Cooke JP (2000) Phytoestrogens and cardiovascular health. JACC 35: 1403-1410
16. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D (1998) The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 91: 6-11
17. Lopez-Virella M, Stone P, Ellis S, Colwell JA (1985) Cholesterol determination in high density lipoprotein separated by three different methods. Clin Chem 31: 746-750
18. Dagen MM, Packard CJ, Shepherd J (1991) A comparison of commercial kits for the measurement of lipoprotein(a). Ann Clin Biochem 28: 359-364
19. Hackler R, Schefer JR, Motzny S, Brand S, Kleine TO, Kaffarnik H, Steinmetz A (1994) Rapid determination of apolipoprotein E phenotypes from whole plasma by automated isoelectric focusing using Phast System and immunofixation. J Lipid Res 35: 153-158
20. Pansini F, Bonaccorsi G, Calisesi M, Campobasso C, Franze GP, Gilli G, Locorotondo G, Mollica G (1993) Influence of spontaneous and surgical menopause on atherogenic metabolic risk. Maturitas 17: 181-190
21. Giada F, Vigna GB, Vitale E, Baldo-Enzi G, Bertaglia M, Crecca R, Fellin R (1995) Effect of age on the response of blood lipids, body composition and aerobic power to physical conditioning and deconditioning. Metabolism 44: 161-165
22. Baum JA, Teng H, Erdman JW, Weigel RM, Klein BP, Persky VW, Freels S, Surya P, Bakhit RM, Ramos E, Shay NF, Potter SM (1998) Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, post-menopausal women. Am J Clin Nutr 68: 545-551
23. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW jr (1998) Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68: 1375S-1379S
24. Nestel PJ, Yamashita T, Sasahara T, Pomeroy S, Dart A, Komesaroff P, Owen A, Abbey M (1997) Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol 17: 3392-3398
25. Expert Panel (1993) Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 269: 3015-3023
26. Sniderman AD, Cianflone K (1996) Measurement of apoproteins: time to improve the diagnosis and treatment of the atherogenic dyslipoproteinemias. Clin Chem 42: 489-491
27. Anderson JW, Johnstone BM, Cook-Newell ME (1995) Meta-analysis of the effect of soy protein intake on serum lipids. N Engl J Med 333: 276-282
28. Van Raaij JMA, Katan MB, West CE, Hautvast JGAJ (1982) Influence of diet containing caseine, soy isolate, and soy concentrate on serum cholesterol and lipoproteins in middle-aged volunteers. Am J Clin Nutr 35: 925-934
29. Meinertz H, Faergeman O, Nilausen K, Chapman MJ, Goldstein S, Laplaud PM (1988) Effects of soy protein and casein in low cholesterol diets on plasma lipoproteins in normolipidemic subjects. Atherosclerosis 72: 63-70
30. Huff MW, Giovannetti PM, Wolfe BM (1984) Turnover of very-low density lipoprotein-apoprotein B is increased by substitution of soybean protein for meat and dairy protein in the diets of hypercholesterolemic men. Am J Clin Nutr 39: 888-897
31. Vessby BOH (1996) Diet and lipoprotein(a). Nutr Metab Cardiovasc Dis 6: 239-244
32. Blankenship J, Crane M, Mullen T, Gregory R, Luken R, Sample C, Cruise R (1995) Serum lipoprotein(a) increased by powder soymilk in subjects on a total vegetarian diet. J Nutr 125: 802S-803S (abstract).
33. Nilausen K, Meinertz H (1999) Lipoprotein(a) and dietary proteins: casein lowers lipoprotein(a) concentrations as compared with soy protein. Am J Clin Nutr 69: 419-425
34. Anthony MS, Clarkson TB, Hughes CL jr, Morgan TM, Burke JL (1996) Soybeans isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal Rhesus monkeys. J Nutr 126: 43-50
35. Honoré EK, Williams JK, Anthony MS, Clarkson TB (1997) Isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril 67: 148-154
36. Adlercreutz H (1990) Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 50: 3S-23S